Role of Tetra Amino Acid Motif Properties on the Function of Protease-Activatable Viral Vectors.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  ACS Biomaterials Science & Engineering

• Publication date

  2016-09-28

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1021/acsbiomaterials.6b00439PMID 29721519PMCID PMC5926792
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Adeno-associated virus (AAV) vectors in cancer gene therapy.

  2016cited by this paper
• Biocomputing nanoplatforms as therapeutics and diagnostics.

  2016cited by this paper
• An essential receptor for adeno-associated virus infection

  2015cited by this paper
• Tunable Protease-Activatable Virus Nanonodes

  2014cited by this paper
• Effective Nanoparticle‐based Gene Delivery by a Protease Triggered Charge Switch

  2014cited by this paper
• Efficiency of Protease-Activatable Virus Nanonodes Tuned Through Incorporation of Wild-Type Capsid Subunits

  2014cited by this paper
• Engineering adeno-associated viruses for clinical gene therapy

  2014cited by this paper
• SCHEMA computational design of virus capsid chimeras: calibrating how genome packaging, protection, and transduction correlate with calculated structural disruption.

  2013cited by this paper
• Matrix metalloproteinases in cancer: their value as diagnostic and prognostic markers and therapeutic targets

  2013cited by this paper
• Selective gene delivery to cancer cells secreting matrix metalloproteinases using a gelatin/polyethylenimine/DNA complex

  2012cited by this paper
• Matrix metalloproteinases and their clinical relevance in urinary bladder cancer

  2011cited by this paper
• Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting

  2011cited by this paper
• Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer.

  2009cited by this paper
• Intracellular targets of matrix metalloproteinase-2 in cardiac disease: rationale and therapeutic approaches.

  2007cited by this paper
• Oncolytic efficacy and enhanced safety of measles virus activated by tumor-secreted matrix metalloproteinases.

  2006cited by this paper
• Heparan Sulfate Proteoglycan Binding Properties of Adeno-Associated Virus Retargeting Mutants and Consequences for Their In Vivo Tropism

  2006cited by this paper
• Targeted retroviral vectors displaying a cleavage site-engineered hemagglutinin (HA) through HA-protease interactions.

  2006cited by this paper
• Library-based selection of retroviruses selectively spreading through matrix metalloprotease-positive cells

  2005cited by this paper
• Identification of Amino Acid Residues in the Capsid Proteins of Adeno-Associated Virus Type 2 That Contribute to Heparan Sulfate Proteoglycan Binding

  2003cited by this paper
• Intracellular Action of Matrix Metalloproteinase-2 Accounts for Acute Myocardial Ischemia and Reperfusion Injury

  2002cited by this paper
• New functions for the matrix metalloproteinases in cancer progression

  2002cited by this paper
• Adeno-Associated Virus Serotype 4 (AAV4) and AAV5 Both Require Sialic Acid Binding for Hemagglutination and Efficient Transduction but Differ in Sialic Acid Linkage Specificity

  2001cited by this paper
• Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy.

  1998cited by this paper
• Membrane-Associated Heparan Sulfate Proteoglycan Is a Receptor for Adeno-Associated Virus Type 2 Virions

  1998cited by this paper
• The action of trypsin on polylysine.

  1953cited by this paper

• Intelligent design of tumor microenvironment-responsive Adeno-associated virus vectors: overcoming delivery barriers and enabling precision therapy

  2025cites this paper
• MMP-9 as a clinical marker for endometriosis: a meta-analysis and bioinformatics analysis

  2024cites this paper
• Hollow Nanomaterials in Advanced Drug Delivery Systems: From Single‐ to Multiple Shells

  2022cites this paper
• Synthetic Biology: Emerging Concepts to Design and Advance Adeno‐Associated Viral Vectors for Gene Therapy

  2021cites this paper
• Membrane-Bound MMP-14 Protease-Activatable Adeno-Associated Viral Vectors for Gene Delivery to Pancreatic Tumors

  2021cites this paper
• Synthetically Engineered Adeno-Associated Virus for Efficient, Safe, and Versatile Gene Therapy Applications.

  2020cites this paper
• Is Viral Vector Gene Delivery More Effective Using Biomaterials?

  2020cites this paper
• Longer Inactivating Sequence in Peptide Lock Improves Performance of Synthetic Protease-Activatable Adeno-Associated Virus.

  2019cites this paper
• Physical, chemical, and synthetic virology: Reprogramming viruses as controllable nanodevices.

  2019cites this paper
• Reducing off target viral delivery in ovarian cancer gene therapy using a protease-activated AAV2 vector platform.

  2019cites this paper
• Rational Engineering and Preclinical Evaluation of Neddylation and SUMOylation Site Modified Adeno-Associated Virus Vectors in Murine Models of Hemophilia B and Leber Congenital Amaurosis

  2019cites this paper
• Protease-Activatable Adeno-Associated Virus Vector for Gene Delivery to Damaged Heart Tissue.

  2019cites this paper
• Adeno-Associated Virus (AAV) Vectors: Rational Design Strategies for Capsid Engineering.

  2018cites this paper
• Stimulus‐responsive viral vectors for controlled delivery of therapeutics

  2017cites this paper